Literature DB >> 4448410

Indices of granulocyte activity in inflammatory bowel disease.

S P Kane, A V Hoffbrand, G Neale.   

Abstract

In conditions with increased neutrophil production, the serum total vitamin B(12)-binding capacity (TBBC) is considered to correlate with the blood pool size of neutrophil granulocytes. The serum lysozyme, on the other hand, is a measure of neutrophil (and monocyte) turnover. The mean serum TBBC was significantly raised in patients with ulcerative colitis (range 1.23-5.51 ng/ml; mean 2.64 ng/ml) and patients with Crohn's disease (range 1.58-9.29 ng/ml; mean 2.93 ng/ml). The elevated values were shown to be due to rises in the granulocyte-secreted binding proteins, transcobalamins I and III. The TBBC was shown to rise with increasing activity of disease and to correlate roughly with the blood neutrophil granulocyte count. Patients with inflammatory bowel disease also had a significantly raised mean level of serum lysozyme (range 3.1 to 10.4 mug/ml; mean 6.8 mug/ml), but there was no correlation in individual patients between serum lysozyme and total B(12)-binding capacity. These results are taken to indicate an enlarged granulocyte pool and increased granulocyte turnover in inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4448410      PMCID: PMC1413077          DOI: 10.1136/gut.15.12.953

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  25 in total

1.  Monocytic vitamin B12-binding protein.

Authors:  R Carmel; C A Coltman
Journal:  Blood       Date:  1971-03       Impact factor: 22.113

2.  Coexistence of pernicious anaemia and chronic myeloid leukaemia: an experiment of nature involving vitamin B12 metabolism.

Authors:  J J Corcino; R Zalusky; M Greenberg; V Herbert
Journal:  Br J Haematol       Date:  1971-05       Impact factor: 6.998

3.  Diagnostic and prognostic values of measurement of serum vitamin B12-binding proteins.

Authors:  V Herbert
Journal:  Blood       Date:  1968-08       Impact factor: 22.113

4.  Rapid determination of vitamin B12-binding alpha- and beta-globulin in serum.

Authors:  E Silverstein; V Herbert
Journal:  Blood       Date:  1968-04       Impact factor: 22.113

5.  Serum muramidase and granulocyte turnover.

Authors:  M E Fink; S C Finch
Journal:  Proc Soc Exp Biol Med       Date:  1968-02

6.  Correation between vario blood white cell pools and the serum B12-binding capaities.

Authors:  G Chikkappa; J Corcino; M L Greenerg; V Herert
Journal:  Blood       Date:  1971-02       Impact factor: 22.113

7.  Pernicious anemia with a normal serum vitamin B-12 level in a case of chronic granulocytic leukemia.

Authors:  R P Britt; D P Rose
Journal:  Arch Intern Med       Date:  1966-01

8.  Significance of changes in serum muramidase activity in megaloblastic anemia.

Authors:  P E Perillie; S S Kaplan; S C Finch
Journal:  N Engl J Med       Date:  1967-07-06       Impact factor: 91.245

9.  Release of vitamin B12--binding protein by human leukocytes in vitro.

Authors:  J Corcino; S Krauss; S Waxman; V Herbert
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

10.  Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia.

Authors:  E F Osserman; D P Lawlor
Journal:  J Exp Med       Date:  1966-11-01       Impact factor: 14.307

View more
  16 in total

1.  Serum lysozyme in inflammatory bowel and coeliac disease.

Authors:  E Mallas; J M Terry; P Asquith; W T Cooke
Journal:  J Clin Pathol       Date:  1976-07       Impact factor: 3.411

2.  Relationship between the transient cAMP increase, exocytosis from specific and azurophil granules and chemotaxis in neutrophil granulocytes.

Authors:  A Naef; B Damerau; H U Keller
Journal:  Agents Actions       Date:  1984-01

3.  Characterization of canine neutrophil granules.

Authors:  R T O'Donnell; B R Andersen
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

4.  Serum lysozyme, serum proteins, and immunoglobulin determinations in nonspecific inflammatory bowel disease.

Authors:  O S El-Khatib; O Lebwohl; A A Attia; C A Flood; J A Stein; J G Sweeting; R T Whitlock; E F Osserman; P R Holt
Journal:  Am J Dig Dis       Date:  1978-04

Review 5.  Serum lysozyme levels in Crohn's disease and ulcerative colitis.

Authors:  T L Peeters; G Vantrappen; K Geboes
Journal:  Gut       Date:  1976-04       Impact factor: 23.059

6.  Immunohistochemical identification of lysozyme in intestinal lesions in ulcerative colitis and Crohn's disease.

Authors:  M Klockars; S Reitamo; J J Reitamo; C Möller
Journal:  Gut       Date:  1977-05       Impact factor: 23.059

7.  Changes in the subcellular distribution of the cytochrome b-245 on stimulation of human neutrophils.

Authors:  R C Garcia; A W Segal
Journal:  Biochem J       Date:  1984-04-01       Impact factor: 3.857

8.  Release of gelatinase from a novel secretory compartment of human neutrophils.

Authors:  B Dewald; U Bretz; M Baggiolini
Journal:  J Clin Invest       Date:  1982-09       Impact factor: 14.808

9.  Vitamin B12 binding protein as a tumour marker for hepatocellular carcinoma.

Authors:  S P Kane; I M Murray-Lyon; F J Paradinas; P J Johnson; R Williams; A H Orr; J Kohn
Journal:  Gut       Date:  1978-12       Impact factor: 23.059

10.  Interferon-gamma activates human neutrophil oxygen metabolism and exocytosis.

Authors:  M A Cassatella; R Cappelli; V Della Bianca; M Grzeskowiak; S Dusi; G Berton
Journal:  Immunology       Date:  1988-03       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.